Table 4.
Subanalysis of ulcer healing rates by H. pylori in the FAS and PPS populations.
| Treatment | FAS population | PPS population | ||
|---|---|---|---|---|
| Hp- [No. (%)] Healed unhealed | Hp+ [No. (%)] Healed unhealed | Hp- [No. (%)] Healed unhealed | Hp+ [No. (%)] Healed unhealed | |
| Rabeprazole 10 mg | 8 (80.0) 2 (20.0) | 36 (90.0) 4 (10.0) | 7 (77.8) 2 (22.2) | 33 (91.7) 3 (8.3) |
| Anaprazole 20 mg | 8 (80.0) 2 (20.0) | 32 (86.5) 5 (13.5) | 6 (75.0) 2 (25.0) | 31 (88.6) 4 (11.4) |
| Anaprazole 40 mg | 7 (70.0) 3 (30.0) | 35 (92.1) 3 (7.9) | 6 (75.0) 2 (25.0) | 34 (94.4) 2 (5.6) |
| Total | 23 (76.7) 7 (23.3) | 103 (89.6) 12 (10.4) | 19 (76.0) 6 (24.0) | 98 (91.6) 9 (8.4) |
FAS, full analysis set; PPS, per-protocol analysis set. Hp, H. pylori.